All topicsTOPIC / FRONTIER COVERAGE

AI for drug discovery

AI for drug discovery is the use of machine learning and computational models to identify drug targets, design and screen candidate molecules, and predict their properties, so that the search for new medicines becomes faster and less reliant on trial and error.

TYPE
Topic
SIGNALS
3
FIRST SEEN
Oct 14, 2026
LAST SEEN
Oct 22, 2026

Recent signals

  • Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation (Rebecca Torrence/Bloomberg) Oct 22, 2026
  • Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million Oct 22, 2026
  • Lab-in-the-Loop at Compute Speed — Ian Quigley, Leash Bio Oct 14, 2026
RELATED
  • OpenAI
  • Kevin Weil
  • ChatGPT
ALL TOPICSLATEST SIGNAL